Article info

Download PDFPDF

Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study

Authors

  1. Correspondence to Professor Frank G Holz, Department of Ophthalmology, University of Bonn, 53127 Bonn, Germany; Frank.Holz{at}ukbonn.de
View Full Text

Citation

Bulirsch LM, Saßmannshausen M, Nadal J, et al
Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study

Publication history

  • Received January 14, 2021
  • Revised March 2, 2021
  • Accepted March 25, 2021
  • First published April 12, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.